Pages that link to "Q34066697"

The following pages link to Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats (Q34066697):

Displaying 137 items.

• Cardiorenal syndrome: the emerging role of protein-bound uremic toxins (Q26830674) ‎ (← links)
• Adult cardiac expression of the activating transcription factor 3, ATF3, promotes ventricular hypertrophy (Q27311483) ‎ (← links)
• CARD9 as a potential target in cardiovascular disease (Q28066993) ‎ (← links)
• The fibrosis-cell death axis in heart failure (Q28076570) ‎ (← links)
• A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy (Q28116093) ‎ (← links)
• Natural product derivative BIO promotes recovery after myocardial infarction via unique modulation of the cardiac microenvironment (Q28597992) ‎ (← links)
• A comparative multi-parametric in vitro model identifies the power of test conditions to predict the fibrotic tendency of a biomaterial (Q33687188) ‎ (← links)
• Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis (Q34218604) ‎ (← links)
• Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II (Q34264496) ‎ (← links)
• Investigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension. (Q34292579) ‎ (← links)
• Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function (Q34304640) ‎ (← links)
• Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. (Q34477882) ‎ (← links)
• Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension (Q34633337) ‎ (← links)
• Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice (Q34667902) ‎ (← links)
• Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort study (Q34816125) ‎ (← links)
• Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction (Q34873552) ‎ (← links)
• Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome (Q35115060) ‎ (← links)
• Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis (Q35151307) ‎ (← links)
• Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice (Q35261976) ‎ (← links)
• PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension (Q35437493) ‎ (← links)
• Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells (Q35538215) ‎ (← links)
• Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6 (Q35571961) ‎ (← links)
• Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise (Q35662458) ‎ (← links)
• Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation (Q35688313) ‎ (← links)
• Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. (Q35710032) ‎ (← links)
• Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure (Q35723859) ‎ (← links)
• Non-human primate and rat cardiac fibroblasts show similar extracellular matrix-related and cellular adhesion gene responses to substance P. (Q35821484) ‎ (← links)
• Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease (Q35856337) ‎ (← links)
• Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart (Q35878968) ‎ (← links)
• Early Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi. (Q35895021) ‎ (← links)
• Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease (Q35903061) ‎ (← links)
• Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype. (Q35965003) ‎ (← links)
• Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure (Q36042371) ‎ (← links)
• Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice. (Q36077608) ‎ (← links)
• β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts (Q36159210) ‎ (← links)
• Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice (Q36350716) ‎ (← links)
• THE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSIS. (Q36407381) ‎ (← links)
• Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome (Q36567326) ‎ (← links)
• Chronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function (Q36677145) ‎ (← links)
• Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways (Q36681664) ‎ (← links)
• Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease (Q36799689) ‎ (← links)
• Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486. (Q36865075) ‎ (← links)
• Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling (Q36873593) ‎ (← links)
• TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis (Q36885519) ‎ (← links)
• Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation (Q36906398) ‎ (← links)
• Cardiac-Specific Disruption of GH Receptor Alters Glucose Homeostasis While Maintaining Normal Cardiac Performance in Adult Male Mice (Q36911630) ‎ (← links)
• Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction (Q36994116) ‎ (← links)
• Signal Transducer and Activator of Transcription 3/MicroRNA-21 Feedback Loop Contributes to Atrial Fibrillation by Promoting Atrial Fibrosis in a Rat Sterile Pericarditis Model (Q37116392) ‎ (← links)
• Effect of Continuous Positive Airway Pressure on Cardiovascular Biomarkers: The Sleep Apnea Stress Randomized Controlled Trial. (Q37166381) ‎ (← links)
• Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts (Q37190230) ‎ (← links)
• Circulating biomarker responses to medical management vs. mechanical circulatory support in severe inotrope-dependent acute heart failure. (Q37337332) ‎ (← links)
• Vasoinhibin, an N-terminal Prolactin Fragment, Directly Inhibits Cardiac Angiogenesis in Three-dimensional Heart Culture (Q37594998) ‎ (← links)
• T cell costimulation blockade blunts pressure overload-induced heart failure (Q37690286) ‎ (← links)
• Therapeutic regulation of cardiac fibroblast function: targeting stress-activated protein kinase pathways (Q37934996) ‎ (← links)
• Myofibroblasts in the infarct area: concepts and challenges (Q37972978) ‎ (← links)
• Inflammatory cytokines in heart failure: mediators and markers (Q38018808) ‎ (← links)
• Epigenetics within the matrix: a neo-regulator of fibrotic disease (Q38034837) ‎ (← links)
• Diagnosing heart failure with preserved ejection fraction (Q38127754) ‎ (← links)
• Investigational drugs targeting cardiac fibrosis (Q38161896) ‎ (← links)
• STAT3, a key regulator of cell-to-cell communication in the heart (Q38187227) ‎ (← links)
• Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction (Q38206408) ‎ (← links)
• Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk (Q38261196) ‎ (← links)
• Interleukin-6: a new therapeutic target in systemic sclerosis? (Q38288110) ‎ (← links)
• Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling (Q38380871) ‎ (← links)
• Gaining myocytes or losing fibroblasts: Challenges in cardiac fibroblast reprogramming for infarct repair (Q38660472) ‎ (← links)
• Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt. (Q38739980) ‎ (← links)
• Understanding STAT3 signaling in cardiac ischemia. (Q38790211) ‎ (← links)
• Physiological and pathological cardiac hypertrophy. (Q38854987) ‎ (← links)
• Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis. (Q38858284) ‎ (← links)
• Epicardial fat thickness, an emerging cardiometabolic risk factor, is increased in young adults born preterm (Q38858866) ‎ (← links)
• Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle (Q38885347) ‎ (← links)
• The role of Epac in the heart. (Q38934306) ‎ (← links)
• An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. (Q39232014) ‎ (← links)
• Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells. (Q39304483) ‎ (← links)
• Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension (Q39382663) ‎ (← links)
• Cardioprotective Effect of Ulmus wallichiana Planchon in β-Adrenergic Agonist Induced Cardiac Hypertrophy (Q39576954) ‎ (← links)
• Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation (Q40286144) ‎ (← links)
• Transcription factor PEX1 modulates extracellular matrix turnover through regulation of MMP-9 expression. (Q40483102) ‎ (← links)
• Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction. (Q41049541) ‎ (← links)
• IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor (Q41222591) ‎ (← links)
• The Cardiomyocyte as a Source of Cytokines in Cardiac Injury (Q41256651) ‎ (← links)
• 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling (Q41810714) ‎ (← links)
• Molecular mechanisms in microRNA-mediated TRB3 gene and hypertension left ventricular hypertrophy (Q41870120) ‎ (← links)
• Brain-mediated dysregulation of the bone marrow activity in angiotensin II-induced hypertension (Q41882282) ‎ (← links)
• p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts (Q42231382) ‎ (← links)
• The ubiquitous interleukin-6: a time for reappraisal (Q42407082) ‎ (← links)
• Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension (Q42784122) ‎ (← links)
• Mediatory role of interleukin-6 in α smooth muscle actin induction and myofibroblast formation around silicone tissue expander. (Q44664941) ‎ (← links)
• Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature (Q46252086) ‎ (← links)
• Atrial Fibrillation Promotion in a Rat Model of Rheumatoid Arthritis (Q47263251) ‎ (← links)
• Experimental Evidences Supporting the Benefits of Exercise Training in Heart Failure (Q48023234) ‎ (← links)
• Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? (Q49106557) ‎ (← links)
• IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway. (Q50512444) ‎ (← links)
• Lentivirus mediated IL-17R blockade improves diastolic cardiac function in spontaneously hypertensive rats (Q50521732) ‎ (← links)
• Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-β1 signaling pathway. (Q51678732) ‎ (← links)
• Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease. (Q53185348) ‎ (← links)
• Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats. (Q54543875) ‎ (← links)
• Acute Hyperthermia Inhibits TGF-β1-induced Cardiac Fibroblast Activation via Suppression of Akt Signaling. (Q55078015) ‎ (← links)
• Epicardial Fat Thickness is Associated with Abnormal Left Ventricle Geometry in Newly Diagnosed Hypertension. (Q55129891) ‎ (← links)
• Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO. (Q55294487) ‎ (← links)
• Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers. (Q55438072) ‎ (← links)
• Deletion of RasGRF1 Attenuated Interstitial Fibrosis in Streptozotocin-Induced Diabetic Cardiomyopathy in Mice through Affecting Inflammation and Oxidative Stress (Q57478296) ‎ (← links)
• Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter Cohort (Q57658287) ‎ (← links)
• Inflammation in Right Ventricular Failure: Does It Matter? (Q58735426) ‎ (← links)
• Cardiac fibrosis: new insights into the pathogenesis (Q58757982) ‎ (← links)
• IFN-β Plays Both Pro- and Anti-inflammatory Roles in the Rat Cardiac Fibroblast Through Differential STAT Protein Activation (Q59805361) ‎ (← links)
• Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy (Q60946704) ‎ (← links)
• Atorvastatin Prevents Myocardial Fibrosis in Spontaneous Hypertension via Interleukin-6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Endothelin-1 (ET-1) Pathway (Q61449284) ‎ (← links)
• Mechanisms of physiological and pathological cardiac hypertrophy (Q63131766) ‎ (← links)
• Elimination of the fibrinogen integrin αβ-binding motif improves renal pathology in mice with sickle cell anemia (Q64057808) ‎ (← links)
• Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation (Q64058077) ‎ (← links)
• Phosphorylation of Hsp20 Promotes Fibrotic Remodeling and Heart Failure (Q64081784) ‎ (← links)
• Cardiac structure and function in patients with schizophrenia taking antipsychotic drugs: an MRI study. (Q64910620) ‎ (← links)
• Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines. (Q64999676) ‎ (← links)
• External Cardioversion of Atrial Fibrillation Causes an Early Improvement of Cardiac Performance: A Longitudinal Strain Analysis Study (Q87980755) ‎ (← links)
• Human Adventitial Fibroblast Phenotype Depends on the Progression of Changes in Substrate Stiffness (Q89915762) ‎ (← links)
• α1-AR overactivation induces cardiac inflammation through NLRP3 inflammasome activation (Q90149907) ‎ (← links)
• Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction (Q90167853) ‎ (← links)
• βIV-Spectrin/STAT3 complex regulates fibroblast phenotype, fibrosis, and cardiac function (Q90255266) ‎ (← links)
• A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity (Q90266648) ‎ (← links)
• Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice (Q90268226) ‎ (← links)
• STAT3 for Cardiac Regenerative Medicine: Involvement in Stem Cell Biology, Pathophysiology, and Bioengineering (Q90362748) ‎ (← links)
• Methylsulfonylmethane decreases inflammatory response to tumor necrosis factor-α in cardiac cells (Q90431614) ‎ (← links)
• Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion (Q90495125) ‎ (← links)
• Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis (Q90623245) ‎ (← links)
• Engineering hiPSC cardiomyocyte in vitro model systems for functional and structural assessment (Q90718914) ‎ (← links)
• Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs (Q91607245) ‎ (← links)
• Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction (Q91640383) ‎ (← links)
• β2-adrenergic stimulation induces interleukin-6 by increasing Arid5a, a stabilizer of mRNA, through cAMP/PKA/CREB pathway in cardiac fibroblasts (Q92014236) ‎ (← links)
• Serum apoptotic marker M30 is positively correlated with early diastolic dysfunction in adolescent obesity (Q92241300) ‎ (← links)
• Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats (Q92535797) ‎ (← links)
• Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging (Q92559389) ‎ (← links)
• Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker? (Q92670725) ‎ (← links)
• Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension (Q92984589) ‎ (← links)
• A potential role of caspase recruitment domain family member 9 (Card9) in transverse aortic constriction-induced cardiac dysfunction, fibrosis, and hypertrophy (Q97539688) ‎ (← links)
• Pathological Responses of Cardiac Mitochondria to Burn Trauma (Q99549050) ‎ (← links)
• Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice (Q99711544) ‎ (← links)